홈 > 시장보고서 > 의료기기 > 정형외과

시장보고서

상품코드

1316301

세계의 스포츠 의학 시장(2023-2030년)

Global Sports Medicine Market - 2023-2030

발행일: 2023년 07월 | 리서치사:

DataM Intelligence | 페이지 정보: 영문 195 Pages | 배송안내 : 1-2일 (영업일 기준)

■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

시장 개요

세계 스포츠 의학 시장은 2022년 70억 달러, 2030년에는 113억 달러에 달할 것으로 예상되며, 수익성 있는 성장이 예상됩니다. 세계 스포츠 의학 시장은 예측 기간(2023-2030) 동안 6.3%의 CAGR을 보일 것으로 예상됩니다.

스포츠 부상 증가, 제품 출시 증가, 새로운 치료법 도입, 재생 의학의 발전, 최소 침습 수술에 대한 요구 증가 등은 예측 기간 동안 세계 스포츠 의학 시장의 성장을 촉진할 것으로 예상되는 요인 중 일부입니다.

시장 역학

시장 발전의 증가로 스포츠 의학 시장 성장 견인

시장 개발의 증가는 예측 기간 동안 세계 스포츠 의학 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어, 2023년 3월 의료 기술 기업 Smith Nephew는 새로운 QUADTRAC 대퇴사두근 힘줄 채취 가이드 시스템, X-WING 이식편 준비 시스템, ULTRABUTTON 조정 가능한 고정 장치 제품군으로 구성된 UltraTRAC QUAD ACL 재건술을 출시했습니다.

또한, 2022년 7월 콜로라도 스프링스에서 열리는 2022 미국정형외과스포츠의학학회(AOSSM) 연례총회에서 세계적인 의료 기술 기업인 Smith Nephew는 정교한 관절 복원 솔루션과 다양한 교육 활동 컬렉션을 포함한 강력한 라인업을 발표했습니다.

스포츠 의학의 발전이 세계 시장에 성장 기회를 가져다 줄 것으로 예상

증가하는 발전은 세계 스포츠 의학 시장에 유리한 성장 기회를 제공하고 있습니다. 예를 들어, 2023년 6월 Aspetar, Orthopaedic, and Sports Medicine Hospital은 충격파 치료를 도입하여 스포츠 의학의 최전선에 서게 되었습니다.

이 최첨단 기술을 적용한 이 최첨단 치료법은 스포츠 관련 부상의 조직 회복과 통증 감소에 변화를 가져왔으며, 운동선수와 개인에게 영향력 있는 영향을 미치고 있습니다.

엄격한 규제기관의 존재는 예측 기간 동안 세계 스포츠 의학 시장을 저해하는 요인으로 작용

스포츠 의학용으로 새로 개발된 의약품의 승인을 위한 엄격한 규제 기관의 존재는 예측 기간 동안 세계 시장의 성장을 저해하고 있습니다. 예를 들어, 스포츠 의학의 승인 및 상용화를 감독하는 주요 규제 기관으로는 미국 식품의약국(USFDA)과 유럽의약품청(EU의 의약품 평가 및 감독을 담당하는 EU의 기관)이 있습니다.

COVID-19 영향 분석

COVID-19 팬데믹과 전 세계 각국의 봉쇄 조치로 인해 모든 산업 분야의 기업 재무 건전성이 영향을 받고 있습니다. 이에 미국 식품의약국(FDA)은 COVID-19 공중보건 비상사태 기간 동안 임상시험 참여자의 안전을 보장하고 임상시험의 무결성 위험을 최소화하기 위한 일반적인 고려사항을 포함한 가이드라인을 발표하여 임상시험 의뢰자와 연구자를 지원하고 임상시험의 안전과 우수 임상시험 관리기준(GCP)을 준수할 수 있도록 했습니다.

러시아-우크라이나 분쟁의 영향 분석

러시아-우크라이나 분쟁은 스포츠 부상 발생률이 낮고 이 지역에는 주요 시장 기업이 없기 때문에 세계 스포츠 의학 시장에 중간 정도의 영향을 미칠 것으로 보입니다. 우크라이나의 진료소는 러시아 군대의 침략을 계속 받아들이고 있으며, 사망자 수가 증가하고 의료 지원이 제한되어 있습니다. 모든 종류의 의약품이 부족합니다. 또한 기본 재료의 수출입의 중요성은 예측 기간 동안 세계 스포츠 의학 시장의 성장에 약간의 영향을 미칠 것으로 예상됩니다.

Market Overview

The global sports medicine market reached US$ 7.0 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 11.3 billion by 2030. The global sports medicine market is expected to exhibit a CAGR of 6.3% during the forecast period (2023-2030).

The increase in the number of sports injuries, rising product launches, introductions of new therapies, advancements in regenerative medicine, and increasing requirements for minimally invasive surgery are among the factors expected to boost the global sports medicine market growth in the forecast period.

Market Dynamics

Increasing Market Developments Drive The Growth of the Sports Medicine Market

The increasing market developments are estimated to boost the global sports medicine market growth in the forecast period. For instnace, in March 2023, Smith+Nephew, medical technology corporation, launched the UltraTRAC QUAD ACL Reconstruction Technique comprising of the new QUADTRAC Quadriceps Tendon Harvest Guide System, X-WING Graft Preparation System and family of ULTRABUTTON Adjustable Fixation Devices.

Likewise, in July 2022, Smith+Nephew, the global medical technology corpoLikewisentroduced a potent line-up featuring a few of its refined joint repair solutions and a wide collection of educational actions in the 2022 American Orthopaedic Society for Sports Medicine (AOSSM) Annual Meeting being held in Colorado Springs.

The Increase Advancements are Expected to Present the Global Sports Medicine Market With Growth Opportunities

The increasing advancements are presenting the global sports medicine market with lucrative growth opportunities. For instnace, in June 2023, Aspetar, Orthopaedic, and Sports Medicine Hospital introduced its Shockwave Therapy putting it at the forefront of sports medicine.

Employing this cutting-edge technology, this state-of-the-art therapy modality is altering tissue restoration and pain drop-in sports-associated injuries, making an influential impact on athletes and individuals.

The Presence of Stringent Regulatory Bodies is Estimated to Hamper the Global Sports Medicine Market During The Forecast Period

The presence of stringent regulatory bodies for the approval of newly developed drugs for sports medicine is hampering the global market growth in the forecast period. For instnace, the major regulatory bodies supervising the authorization and commercialization of sports medicine include the United States Food and Drug Administration (USFDA) and the European Medicines Agency, an agency of the European Union in charge of the evaluation and supervision of pharmaceutical products in the European Union.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is thought to hold a moderate influence on the global sports medicine market, as there is a low incidence of sports injuries and a lack of primary market players in this region. Though continuing to countenance invasions from Russian armies, Ukrainian clinics are forced by growing numbers of deaths and limited medical aid. There are shortages across all Products of medications. Again, the significance of the import and export of fundamental materials are expected to slightly impact the global sports medicine market growth in the forecast period.

Segment Analysis

The global sports medicine market is segmented based on product, application, end-user, and region.

The Ankle & Foot Injuries Application is Estimated to Dominate the Global Sports Medicine Market

Owing to the increasing product introduction for the foot and ankle sports-injury applications segment into the global sports medicine market, the segment is estimated to hold a large share of the global market accounting for about 43.9%. For instance, in June 2022, Mueller Sports Medicine, an industry leader in sports medicine for the last six decades, launched its SKY Ankle Stabilizer.

As ankle sprains are the No.1 sports injury, SKY Stabilizer strives to deliver fit ankles and avert chronic ankle instability. It was developed for participants interested in vertical jumping sports such as basketball and volleyball as Mueller concentrated on simple elements of inversion sprains and biomechanics.

Geographical Analysis

Europe is Estimated to Hold 27.6% of the Market Share Owing to the Growing Cases of Chronic Conditions in this Region

Owing to the increasing incidences of sports injury in this region the European sports medicine market is estimated to hold around 27.6% of the global market share by 2030. For instance, in September 2022, London - Howden, the international insurance vendor, reported its European Football Injury Index for the 2021/2022 season for the guys' tournament, which demonstrates that injury expenses for the mainland's leading leagues broke via the half-a-billion-pound spot for the very foremost term (£513.23m/€610.75m). The whole number of injuries sustained throughout Europe's top five clubs was around 4,810 over the course of the previous season denoting a 20% boost in the 2020/2021 season.

Competitive Landscape

The major global players in the sports medicine market include: Arthrex Inc., CONMED Corporation, Johnson & Johnson, Medtronic PLC, Mueller Sports Medicine Inc., Performance Health, Smith & Nephew, Stryker Corporation, Wright Medical Group, Zimmer Biomet Holdings Inc. among others.

Why Purchase the Report?

To visualize the global sports medicine market segmentation based on product, application, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of sports medicine market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available in Excel consisting of key products of all the major players.

The global sports medicine market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Market Developments
  - 4.1.1.2. Growing Incidences of Sports Injuries
- 4.1.2. Restraints
  - 4.1.2.1. Stringent Regulatory Authorities
- 4.1.3. Opportunity
  - 4.1.3.1. Increasing Advancements
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Body Reconstruction and Repair *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Body Support and Recovery
7.4. Body Monitoring and Evaluation Devices
7.5. Accessories

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Ankle & Foot Injuries*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Back & Spine Injuries
8.4. Elbow & Wrist Injuries
8.5. Hip Injuries
8.6. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Other

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. The U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. The U.K.
  - 10.3.6.3. France
  - 10.3.6.4. Spain
  - 10.3.6.5. Italy
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Arthrex Inc.*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. CONMED Corporation
12.3. Johnson & Johnson
12.4. Medtronic PLC
12.5. Mueller Sports Medicine Inc.
12.6. Performance Health
12.7. Smith & Nephew
12.8. Stryker Corporation
12.9. Wright Medical Group
12.10. Zimmer Biomet Holdings Inc.

LIST NOT EXHAUSTIVE

13. Appendix

13.1. About Us and Services
13.2. Contact Us

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF & Excel (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,350

￦ 6,173,000

PDF & Excel (Multiple User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,850

￦ 6,882,000

PDF & Excel (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,850

￦ 11,139,000

※ 부가세 별도